Nan Fung Group Holdings
Nan Fung Group Holdings reported 29 stocks worth $150M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are LBRX (16.2%), MPLT (15.7%) and OBX (8.4%). Compared with Q2 2026, the fund opened new positions in OBX, NUVB and NAMS, added to MPLT and PCOR, trimmed RXRX and sold out of CHYM.
Latest filing: what Nan Fung Group Holdings did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() LBRX LB Pharmaceuticals Inc | $24.2M | 16.2% | 631K | No change | 5 of 8 | |
| 2 | ![]() MPLT Maplight Therapeutics Inc | $23.4M | 15.7% | 2.3M | +1.3M (+137%) | 4 of 8 | |
| 3 | ![]() OBX Obsidian Therapeutics Inc | $12.6M | 8.4% | 919K | New position | 1 of 8 | |
| 4 | CYBIN INC | $12.1M | 8.1% | 987K | No change | 4 of 8 | |
| 5 | ![]() EVMN Evommune Inc | $11.9M | 8.0% | 1.4M | No change | 4 of 8 | |
| 6 | ![]() NUVB Nuvation Bio Inc | $7.4M | 5.0% | 1.3M | New position | 1 of 8 | |
| 7 | ![]() INCY Incyte Corp | $6.5M | 4.4% | 54K | No change | 8 of 8 | |
| 8 | ![]() ONC Beone Medicines Ltd | $5.8M | 3.8% | 16K | No change | 8 of 8 | |
| 9 | ![]() RYTM Rhythm Pharmaceuticals Inc | $4.7M | 3.1% | 49K | No change | 8 of 8 | |
| 10 | ![]() PCOR Procore Technologies Inc | $4.6M | 3.1% | 89K | +36K (+67%) | 4 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() CHYM Chime Finl Inc | $432K | 21K |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 13, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Nan Fung Group Holdings 13F FAQ
What does Nan Fung Group Holdings own?
Nan Fung Group Holdings reported 29 stocks worth $150M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are LBRX (16.2%), MPLT (15.7%) and OBX (8.4%). The table above lists every position in the filing (the top 10 without an account).
What did Nan Fung Group Holdings buy and sell in Q3 2026?
Compared with Q2 2026: 5 new positions, 2 added to, 1 trimmed and 1 sold out. New positions include OBX, NUVB and NAMS. It sold all of CHYM.
When will Nan Fung Group Holdings file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Nan Fung Group Holdings's portfolio worth?
The Q3 2026 filing reports $150M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.













